ITGAX and cancer: COX-2fl/fl CD11c-cre+ and COX-2fl/fl Lyz2-cre+ mice were immunized with 107 CFU of a live-attenuated, vaccine strain of L. monocytogenes (LADD L. monocytogenes) currently used in clinical trials as a cancer therapy platform [30].